- Home
- APA vs TFX Comparison
APA vs TFX Comparison
Compare APA & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APA
- TFX
- Stock Information
- Founded
- APA 1954
- TFX 1943
- Country
- APA United States
- TFX United States
- Employees
- APA N/A
- TFX N/A
- Industry
- APA Oil & Gas Production
- TFX Medical/Dental Instruments
- Sector
- APA Energy
- TFX Health Care
- Exchange
- APA Nasdaq
- TFX Nasdaq
- Market Cap
- APA 8.7B
- TFX 8.3B
- IPO Year
- APA N/A
- TFX N/A
- Fundamental
- Price
- APA $23.70
- TFX $182.53
- Analyst Decision
- APA Hold
- TFX Buy
- Analyst Count
- APA 19
- TFX 7
- Target Price
- APA $30.06
- TFX $252.50
- AVG Volume (30 Days)
- APA 6.3M
- TFX 496.2K
- Earning Date
- APA 02-19-2025
- TFX 02-20-2025
- Dividend Yield
- APA 4.21%
- TFX 0.75%
- EPS Growth
- APA 34.29
- TFX N/A
- EPS
- APA 6.58
- TFX 5.03
- Revenue
- APA $8,955,000,000.00
- TFX $3,025,824,000.00
- Revenue This Year
- APA $12.71
- TFX $4.56
- Revenue Next Year
- APA N/A
- TFX $4.76
- P/E Ratio
- APA $3.60
- TFX $35.88
- Revenue Growth
- APA 6.11
- TFX 2.27
- 52 Week Low
- APA $20.32
- TFX $171.69
- 52 Week High
- APA $36.05
- TFX $256.85
- Technical
- Relative Strength Index (RSI)
- APA 53.09
- TFX 51.44
- Support Level
- APA $23.40
- TFX $175.44
- Resistance Level
- APA $25.83
- TFX $185.35
- Average True Range (ATR)
- APA 0.77
- TFX 4.38
- MACD
- APA 0.12
- TFX 1.22
- Stochastic Oscillator
- APA 45.24
- TFX 77.74
About APA APA Corporation
Based in Houston, APA is an independent exploration and production company. It operates primarily in the US, Egypt, the North Sea, and Suriname. At year-end 2023, proved reserves totaled 807 million barrels of oil equivalent, with net reported production of 405 thousand boe/day that year (64% of which was oil and natural gas liquids, with the remainder natural gas).
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.